Abstract | BACKGROUND: METHODS: A total of 761 consecutive adult patients who underwent off-pump coronary artery bypass grafting were retrospectively reviewed. The majority (87%) received aspirin preoperatively. Heparin was intravenously administered for a kaolin-based activated clotting time of greater than 300 seconds. Aprotinin was administered as a 1 million or 2 million kallikrein inhibiting unit bolus to 391 patients after median sternotomy. The control group (n = 370) underwent surgery during the same period without receiving aprotinin. Blood loss was measured intraoperatively (cell-saving device) and postoperatively by quantifying mediastinal chest tube drainage. RESULTS:
Aprotinin was associated with a significant reduction in postoperative blood loss (p < 0.001) and less excessive postoperative hemorrhage (p < 0.001) compared with the control group. Transfusion rates and amount of blood products administered were also reduced by aprotinin (p < 0.01 for both). Significantly more patients in the aprotinin group were free of any blood product transfusion (54.7%) compared with the control group (41.4%; p < 0.01). The safety profile was comparable between aprotinin and control patients. CONCLUSIONS:
|
Authors | Hartmuth B Bittner, Janine Lemke, Michelle Lange, Ardawan Rastan, Friedrich W Mohr |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 85
Issue 5
Pg. 1662-8
(May 2008)
ISSN: 1552-6259 [Electronic] Netherlands |
PMID | 18442562
(Publication Type: Journal Article)
|
Chemical References |
- Hemostatics
- Serine Proteinase Inhibitors
- Aprotinin
|
Topics |
- Aged
- Aprotinin
(administration & dosage)
- Blood Loss, Surgical
(physiopathology, prevention & control)
- Blood Transfusion
- Coronary Artery Bypass, Off-Pump
- Erythrocyte Count
- Female
- Hematocrit
- Hemoglobinometry
- Hemostatics
(administration & dosage)
- Humans
- Male
- Middle Aged
- Postoperative Hemorrhage
(blood, prevention & control)
- Serine Proteinase Inhibitors
(administration & dosage)
- Treatment Outcome
|